Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Formerly About Advanced Micro Devices -- Ignore unavailable to you. Want to Upgrade?

To: J_F_Shepard who wrote (504978)	8/14/2009 9:43:10 PM
From: Brumar89	Read Replies (1) \| Respond to of 1578133

LOL now you're claiming to know whether people in other parts of the country wash their hands in bathrooms. You really are weird. I'm not ignoring the 100K deaths from our stupid health care workers who don't wash their hands. I keep asking you what Obama will do about it? What is your answer?

To: J_F_Shepard who wrote (504978)	8/14/2009 9:53:01 PM
From: longnshort	Read Replies (1) \| Respond to of 1578133

Medical error has received a great deal of attention in recent years. The phrase "medical error" is an umbrella term given to all errors that occur within the healthcare system including mishandled surgery, diagnostic errors, equipment failures, and medication errors (MEs). Medical error is a large problem in the UK and the US, in both primary and secondary care, and policy initiatives have been implemented to reduce it.[1-5] MEs are probably one of the most common types of medical error. In the US, it has been estimated that MEs kill 7000 patients a year.[1] In UK hospitals, the incidence and consequences of MEs seem similar to those reported in the US: prescribing errors occur in 1.5% of prescriptions, and administration errors occur in 3-8% of nonintravenous doses given.[6,7] Much of the research into MEs and their prevention has been performed in facilities that care primarily for adults. Information on the incidence of MEs in pediatrics is scarce. Pediatrics poses a unique set of risks, predominantly because of wide variation in body mass, which requires doses to be calculated individually based on patient age, weight or body surface area, and clinical condition. This increases the likelihood of errors, particularly dosing errors.[8] In addition, dosage formulations are often extemporaneously compounded to meet the need for small doses in these patients, and there is a lack of information on pediatric doses and indications.[9] In a one week study of over 10 000 UK hospital beds, it was shown that the number of pharmacist interventions (most of which relate to prescribing errors) was higher in pediatric wards than in geriatric, medical, or surgical wards.[10] In addition, there is recent evidence from the US that potentially harmful MEs may be 3 times more common in the pediatric population than in adults.[11] This suggests that the epidemiologic characteristics of MEs may be different between adults and children. The situation in the UK is not clear. It has been estimated that 1675 avoidable MEs occur each year in UK pediatric inpatients.[12] However, this figure is based on spontaneous reporting of MEs and is therefore likely to be a gross underestimate due to underreporting. Our objectives were to review studies of the incidence of MEs in pediatric patients and to identify common types of error in this patient group. The literature on MEs needs to be evaluated carefully, as there are several methodological issues that can markedly affect the interpretation of findings.[8] These issues, summarized by Wong et al.,[8] include the definition of ME used, the method by which MEs are detected, and the setting studied.